|
GDPD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.194600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.74869999999872E-05 |
| Normal-vs-Stage2 |
9.002600E-01 |
| Normal-vs-Stage3 |
6.846900E-04 |
| Normal-vs-Stage4 |
2.66910000001896E-06 |
| Stage1-vs-Stage2 |
6.763200E-03 |
| Stage1-vs-Stage3 |
7.410200E-01 |
| Stage1-vs-Stage4 |
1.134420E-01 |
| Stage2-vs-Stage3 |
4.962700E-03 |
| Stage2-vs-Stage4 |
6.034100E-04 |
| Stage3-vs-Stage4 |
2.410000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.79659999996773E-06 |
| Normal-vs-AfricanAmerican |
1.772400E-01 |
| Normal-vs-Asian |
2.8480999999525E-06 |
| Caucasian-vs-AfricanAmerican |
1.264790E-01 |
| Caucasian-vs-Asian |
1.739790E-01 |
| AfricanAmerican-vs-Asian |
6.188100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8822199999935E-05 |
| Normal-vs-Female |
1.077720E-03 |
| Male-vs-Female |
1.358370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.768000E-04 |
| Normal-vs-Age(41-60Yrs) |
5.66309999999737E-05 |
| Normal-vs-Age(61-80Yrs) |
6.775800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.030100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.580000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.902300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.910600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.411900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.619000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.446000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.142030E-02 |
| Classical-VS-Follicular |
4.66269999999103E-06 |
| Classical-VS-Other |
6.776400E-01 |
| Classical-VS-Normal |
9.79610000007014E-07 |
| Tall-VS-Follicular |
2.99410000126343E-08 |
| Tall-VS-Other |
6.833400E-01 |
| Tall-VS-Normal |
2.53109999626133E-08 |
| Follicular-VS-Other |
9.293700E-02 |
| Follicular-VS-Normal |
7.538200E-01 |
| Other-VS-Normal |
2.603600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.231500E-02 |
| Normal-vs-N1 |
1.51440004980685E-09 |
| N0-vs-N1 |
3.16780000009231E-07 |
|
|
